Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Ubiquitination and downregulation of ErbB2 and estrogen receptor-alpha by kinase inhibitor MP-412 in human breast cancer cells.
Suzuki T, Fujii A, Ochi H, Nakamura H.
J Cell Biochem. 2011 Sep;112(9):2279-86. doi: 10.1002/jcb.23147.
Related citations
The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.
Lu Y, Zhou H, Chen W, Zhang Y, Hamburger AW.
Breast Cancer Res Treat. 2011 Feb;126(1):27-36. Epub 2010 Apr 9.
Quercetin-induced ubiquitination and down-regulation of Her-2/neu.
Jeong JH, An JY, Kwon YT, Li LY, Lee YJ.
J Cell Biochem. 2008 Oct 1;105(2):585-95.
Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin.
Jung Y, Xu W, Kim H, Ha N, Neckers L.
Biochim Biophys Acta. 2007 Mar;1773(3):383-90. Epub 2006 Nov 10.
Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu.
Xu W, Marcu M, Yuan X, Mimnaugh E, Patterson C, Neckers L.
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12847-52. Epub 2002 Sep 18.
Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy.
Citri A, Alroy I, Lavi S, Rubin C, Xu W, Grammatikakis N, Patterson C, Neckers L, Fry DW, Yarden Y.
EMBO J. 2002 May 15;21(10):2407-17.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on